Advertisement

Topics

greenovation Biotech GmbH Company Profile

11:14 EDT 20th June 2018 | BioPortfolio

greenovation is a privately held biotechnology company based in Freiburg, Germany. Venture capital investors are Mediport Venture, Berlin, and the Seed Group, Tuebingen. Incorporated in 1999, the company has developed a safe and cost-effective production platform for complex biopharmaceuticals.
greenovation®'s moss bioreactor is a major innovation in the manufacture of biopharmaceuticals including safety and cost advantages of plant-based systems and at the same time avoiding risks associated with environmental release.

Location

Boetzinger Str. 29 b
Freiburg
D-79111
Germany

Contact

Phone: 49 761 470 99 0
Fax: 49 761 470 99 190
Email: info@greenovation.com


News Articles [1911 Associated News Articles listed on BioPortfolio]

PH-FIX Indikatorstäbchen pH 4,5-10 100 St MACHEREY-NAGEL GMBH & CO. KG

EUR 10,24Angebotsende: Samstag Apr-7-2018 11:22:08 CESTSofort-Kaufen für nur: EUR 10,24Sofort-Kaufen | Zur Liste der beobachteten Artikel hinzufügen Biotech365 : PH-FIX Indikatorstäbchen pH 4,...

Systec GmbH Introduces its new Business Partner Evidencia GmbH

Research, pharmaceuticals, life sciences and food: many laboratories rely on steam sterilizers or equipment where processes are monitored using pressure and temperature control. Thanks to our collabor...

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

Original-Research: CO.DON AG (von Sphene Capital GmbH): Buy

Original-Research: CO.DON AG - von Sphene Capital GmbH Einstufung von Sphene Capital GmbH zu CO.DON AG Unternehmen: CO.DON AG ISIN: DE000A1K0227 Anlass der Studie: Update Report Empfehlung: Buy se...

Original-Research: Medigene AG (von EQUITS GmbH): Kaufen

Original-Research: Medigene AG - von EQUITS GmbH Einstufung von EQUITS GmbH zu Medigene AG Unternehmen: Medigene AG ISIN: DE000A1X3W00 Anlass der Studie: Übernahme-Angebot Empfehlung: Kaufen Kursz...

BB Biotech: "Kleine überzeugen"

Die Aktie der Schweizer Beteiligungsgesellschaft BB Biotech gilt als das Basisinvestment im Biotech-Sektor. Und das zu Recht: Regelmäßig gelingt es den Schweizern, die Benchmark, den Nasdaq Biotech....

Biotech Report: 4SC und BB Biotech fester

(shareribs.com) Frankfurt / New York 13.06.18 - Biotech-Werte zeigten sich im deutschen Handel durchwachsen. Mit 4SC und BB Biotech gab es durchaus Gewinner, auf der anderen Seite standen unter and...

BB Biotech: Viele wichtige News 2018

Die Schweizer Biotech-Beteiligungsgesellschaft BB Biotech hat am Freitag den Geschäftsbericht 2017 veröffentlicht. Wieder einmal ist der dem Unternehmen die Benchmark Nasdaq Biotech Index zu schlag....

PubMed Articles [54 Associated PubMed Articles listed on BioPortfolio]

Biotech Crop Planting Resumes High Adoption in 2016.

The global area of biotech crops in 2016 increased from 179.7 million hectares to 185.1 million hectares, a 3% increase equivalent to 5.4 million hectares. Some 26 countries planted biotech crops, 19 ...

Just how good an investment is the biopharmaceutical sector?

Uncertainty surrounding the risk and reward of investments in biopharmaceutical companies poses a challenge to those interested in funding such enterprises. Using data on publicly traded stocks, we tr...

Third-quarter biotech job picture.

Research biotech patenting 2017.

Correction to: Lonoctocog Alfa: A Review in Haemophilia A.

The article Lonoctocog Alfa: A Review in Haemophilia A, written by Zaina T. Al-Salama and Lesley J. Scott, was originally published Online First without open access. After publication in volume 77...

Clinical Trials [56 Associated Clinical Trials listed on BioPortfolio]

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

A Phase 3 Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects

The purpose of this single-centre, randomized, double-blind, parallel control, phase 3 study is to evaluate the safety and immunogenicity of a rabies vaccine (Vero Cell) for human use in h...

Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides

Pevion Biotech has designed a therapeutic vaccine to treat patients who suffer from chronic hepatitis C virus infection. The vaccine is based on a combination of the PeviPRO and PeviTER pl...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Companies [1408 Associated Companies listed on BioPortfolio]

greenovation Biotech GmbH

greenovation is a privately held biotechnology company based in Freiburg, Germany. Venture capital investors are Mediport Venture, Berlin, and the Seed Group, Tuebingen. Incorporated in 1999, the comp...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

FGK Clinical Research GmbH

As contract research organization FGK GmbH provides a wide range of services in drug and medical device development from early conception until final report. FGK has a focus on biotech companies which...

NIGU Chemie GmbH

Nigu Chemie GmbH is the competence center for nitroguanidine and ultrapure guanidine salts in the business unit Fine Chemicals of the new Degussa AG. We are manufacturing and developing from laborator...

More Information about "greenovation Biotech GmbH" on BioPortfolio

We have published hundreds of greenovation Biotech GmbH news stories on BioPortfolio along with dozens of greenovation Biotech GmbH Clinical Trials and PubMed Articles about greenovation Biotech GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of greenovation Biotech GmbH Companies in our database. You can also find out about relevant greenovation Biotech GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record